Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog
April 20, 2021

[vc_row][vc_column][vc_single_image image="42214" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Dubbed one of the notorious ‘silent killers’, ovarian cancer claims the lives of approximately 14,000 American women each year. Tragically, all women are at risk, and early detection and sustainable treatment have proved to be difficult. However, a recent study provides...

, ,

by
Blog
March 15, 2021

[vc_row][vc_column][vc_single_image image="41711" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]When people hear the word “vaccine”, they often think about vaccine’s preventive function that protects people from getting infectious diseases such as flu, hepatitis or Covid-19.  It’s true that traditional vaccines are developed to prevent infectious diseases, but innovative scientists...

, , ,

by
Blog
February 23, 2021

[vc_row][vc_column][vc_column_text css=""] Did you know that cancer patients have a high risk of oral and dental complications? It is no secret that chemotherapy, radiation, and other cancer treatments are often accompanied by a variety of mild to severe side effects. Many of these side effects can be...

by
Blog
January 21, 2021

[vc_row][vc_column][vc_single_image image="40075" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Immuno-oncology (IO) drugs have demonstrated unprecedented benefits in the treatment of several types of cancer. The overall survival time of cancer patients treated by IO drugs have been dramatically extended, and in some cases, even late stage fatal cancers are...

, ,

by
Blog, Coronavirus
January 21, 2021

[vc_row][vc_column][vc_single_image image="40066" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] New publication by NFCR-supported scientist Rakesh Jain, Ph.D., applies cancer research findings to help COVID-19 treatment in different patient groups. Few drugs for COVID-19 appear to work well in unselected patients, but now a new mathematical model provides insight into...

, ,

by
Blog
January 13, 2021

[vc_row][vc_column][vc_column_text css=""] The National Foundation for Cancer Research (NFCR) answers some of the most frequently asked questions about biosimilar drugs for cancer treatment. Biologic drugs (biologics) are a special class of medications that are made from living organisms, such as proteins.1 Vaccines, hormones, and anti-allergy medications are...

by
Blog
December 15, 2020

[vc_row][vc_column][vc_column_text css=""] New approach developed by Dr. Rakesh Jain and his research team identifies biomarkers that may indicate which patients will best respond to immune checkpoint blockade therapies. A research team led by NFCR-supported scientist Rakesh K. Jain, PhD, the Andrew Werk Cook Professor of Tumor Biology...

, , ,